Tag Archives: BIO

Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2014 Unaudited Financial Results

BEIJING, April 10, 2015 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for…

Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma

– Anisina kills melanoma cells regardless of their mutation status – Melanoma cells with normal and mutated BRAF gene killed by Anisina – Anisina to come into the clinic as…

Latin American Contract Research Organizations Set to Get More Local Outsourcing Opportunities

– Currently, multinational companies outsource a larger proportion of their clinical trials than local firms, finds Frost & Sullivan SAO PAULO, April 7, 2015 /PRNewswire/ — As market penetration stood at…

Resverlogix Receives Two Patents for RVX-208 in China

CALGARY, Alberta, April 7, 2015 /PRNewswire/ — Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) announces that it has received two China patent approvals covering RVX-208. A composition of matter…

SAFC Launches New EX-CELL® Advanced™ Products for Scalable, Efficient Biopharmaceutical Manufacturing

ST. LOUIS, April 7, 2015 /PRNewswire/ — Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), the Company’s business unit providing products and services for use in regulated pharmaceutical…

WuXi PharmaTech Lists Shares of Small-Molecule Manufacturing Subsidiary STA on New Third Board in China

SHANGHAI, April 2, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, announced…

Novogen Engages Leading US Investor Relations Firm

SYDNEY, April 2, 2015 /PRNewswire/ — Novogen Ltd (ASX:NRT NASDAQ:NVGN) today announced it has appointed US-based public relations firm, PCG Advisory (PCG), to drive the Company’s investor-awareness program in the…

Investment Banker Appointed CEO of Australian Health Tech Start-Up

Australian start-up, Sonoa Health, has today appointed a respected investment banker as CEO. His mission: bring an innovative product to market, secure strategic partnerships, and expand internationally SAN FRANCISCO, March…

Yale University and Novogen Release Data on Cantrixil Mode of Action

Key data confirming Cantrixil kills ovarian cancer stem cells Unique action of inhibiting pro-survival mechanisms and promoting pro-death mechanisms SYDNEY, March 30, 2015 /PRNewswire/ — US-Australian drug discovery company, Novogen…